Inscription Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Inscription Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Inscription Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $228k 2.4k 95.03
2024-06-30 $220k 2.4k 91.48
2024-03-31 $218k 2.4k 90.70

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Bank of America Corporation (BAC)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Nike CL B (NKE)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Chevron Corporation (CVX)
Ishares Tr Intl Trea Bd Etf (IGOV)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)

View all positions for Inscription Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
J.Safra Asset Management
Mivtachim The Workers Social Insurance Fund
Miller Investment Management
Thrivent Financial for Lutherans
Adamsbrown Wealth Consultants
Two Sigma Investments
Prime Capital Investment Advisors
Bank of America Corporation
Morgan Stanley
Susquehanna International
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance

View all funds holding Vaneck Vectors Pharmaceutical etf